ERAP2 and cervical cancer: Additionally, the allelic and genotypic distributions of rs2248374 (P = 0.015 and 0.041, respectively) and rs2287988 (P = 0.014 and 0.039) in ERAP2 were significantly different between CIN and cervical cancer groups (Table 3).